Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.
Jacob S. Aday, Alan K. Davis, Cayla M. Mitzkovitz, Emily K. Bloesch, Christopher C. Davoli
ACS Pharmacol Transl Sci March 5, 2021 DOI: 10.1021/acsptsci.1c00014 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Placebo-controlled Peer reviewed |
|---|---|
| Keywords | Psychedelics Psychedelic experiences Drug effects Individual differences Personal characteristics Personality traits Openness Current mindsets Psychological states Beneficial outcomes Optimize therapeutic potential Psychological factors |
| Citations | 228 |
| Key findings | Baseline traits of absorption, openness, and acceptance, along with a state of surrender, predict positive acute psychedelic experiences, while low openness, low surrender, and preoccupied or confused states predict adverse reactions. |
Abstract
Psychedelic drugs are increasingly being incorporated into therapeutic contexts for the purposes of promoting mental health. However, they can also induce adverse reactions in some individuals, and it is difficult to predict before treatment who is likely to experience positive or adverse acute effects. Although consideration of setting and dosage as well as excluding individuals with psychotic predispositions has thus far led to a high degree of safety, it is imperative that researchers develop a more nuanced understanding of how to predict individual reactions. To this end, the current systematic review coalesced the results of 14 studies that included baseline states or traits predictive of the acute effects of psychedelics. Individuals high in the traits of absorption, openness, and acceptance as well as a state of surrender were more likely to have positive and mystical-type experiences, whereas those low in openness and surrender or in preoccupied, apprehensive, or confused psychological states were more likely to experience acute adverse reactions. Participant sex was not a robust predictor of drug effects, but 5-HT2AR binding potential, executive network node diversity, and rACC volume may be potential baseline biomarkers related to acute reactions. Finally, increased age and experience with psychedelics were individual differences related to generally less intense effects, indicating that users may become slightly less sensitive to the effects of the drugs after repeated usage. Although future well-powered, placebo-controlled trials directly comparing the relative importance of these predictors is needed, this review synthesizes the field's current understanding of how to predict acute reactions to psychedelic drugs.